Thomas Handler: Statement High Energy Experimental Physics efforts in the USA is at a crossroad. Three large scale accelerator physics experiments, BaBar at SLAC and D0 and CDF at FNAL, are in their final phases. Even with the accelerator based neutrino experiments that are in process or being brought on at FNAL, the number of experiments available for students, post-doctoral research fellows and faculty is insufficient to accommodate those wanting to do HEP in the USA. For the last two years I have participated in the annual trips to Washington D.C. to meet with either members of Congress or their staff. These trips have highlighted the fact that the High Energy Physics program is looked upon favorably - up to a point. They understand the skills that our students our trained in and that these students often end up in other disciplines contributing to the well being of the USA. However these visits have also pointed out that there are several concerns on the Hill with regards to HEP. One of the main concerns was with the shifting of the center of gravity from the USA to CERN and the LHC. Recently a significant effort has been launched with regards to the ILC centered at FNAL. However, recent pronouncements from Washington have implied that the ILC may be further in time than originally expected. It was strongly suggested that an intermediate, bridging, program be developed at FNAL to do physics. This is important. An accelerator based experimental program that is based in the USA will be a place for those students or physicists who do not have a desire or the means to go the LHC. These experiments can and would be an attractor for future students from the USA and overseas. If elected to the UEC, I would work to ensure that a strong and viable HEP experimental program in the USA remains in place. I would also work to relate the concerns and wishes of the HEP community to the Fermilab Directorate. I would also continue with the UEC trips to Washington to continue to foster the relationships that have been developed over the last several years. Again, HEP in the USA is at a crossroad. We must be sure that the path that is taken ensures the viability of the experimental program in the USA.